Ashish M. Kamat, President of IBCG, Associated Editor at European Urology Oncology, shared a post on X:
“Pleased to share that the 2026 National Comprehensive Cancer Network (NCCN) Bladder Cancer Guidelines now incorporate the IBCG risk stratification framework for intermediate-risk NMIBC.
A milestone reflecting more than a decade of collaborative work by colleagues worldwide.”
Other articles about NCCN on OncoDaily.